PharmaBlock

PharmaBlock is a mission-driven, globally integrated partner dedicated to accelerating pharmaceutical R&D and manufacturing through innovative chemistry and sustainable technologies. Founded in 2013 and publicly traded (300725.SZSE), the company has evolved from a supplier of novel chemical building blocks into a full-service CDMO, partnering with nearly all top-20 pharma companies and hundreds of biotechs. Its strategy hinges on a dual foundation: a vast library of proprietary building blocks that enable drug discovery and a differentiated low-carbon manufacturing platform that enhances efficiency, safety, and environmental sustainability for commercial-scale production.

A dual-pillar platform combining a vast library of novel chemical building blocks for drug discovery with a proprietary low-carbon manufacturing technology suite (e.g., continuous flow chemistry, micropacked bed hydrogenation) for efficient, scalable, and sustainable process development and commercial production.

Competes with large diversified CDMOs (e.g., Lonza, Catalent) and chemical suppliers, as well as leading Asian CDMOs (e.g., WuXi AppTec). Differentiation is achieved through deep chemistry roots, an integrated building-block-to-manufacturing model, and a focused low-carbon technology platform.